offline
Amgen (AMGN) Beats Q4 Earnings Estimates
Zacks Equity Research
Amgen (AMGN) came out with quarterly earnings of $4.36 per share, beating the Zacks Consensus Estimate of $4.14 per share. This compares to earnings of $3.81 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.31%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $4.22 per share when it actually produced earnings of $4.67, delivering a surprise of 10.66%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Amgen , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $6.85 billion for the quarter ended December 2021, missing the Zacks Consensus Estimate by 0.98%. This compares to year-ago revenues of $6.63 billion.
...
https://finance.yahoo.com/news/amgen-amg...10503.html
![[Bild: AMGNw161865056i.png]](https://finviz.com/publish/020822/AMGNw161865056i.png)
Zacks Equity Research
Amgen (AMGN) came out with quarterly earnings of $4.36 per share, beating the Zacks Consensus Estimate of $4.14 per share. This compares to earnings of $3.81 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.31%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $4.22 per share when it actually produced earnings of $4.67, delivering a surprise of 10.66%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Amgen , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $6.85 billion for the quarter ended December 2021, missing the Zacks Consensus Estimate by 0.98%. This compares to year-ago revenues of $6.63 billion.
...
https://finance.yahoo.com/news/amgen-amg...10503.html
__________________
